SCHEMBL1492084

SCHEMBL1492084

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CCC4CC(O)(O)C(O)(O)C[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 4/20 0.70
HSD17B10 Q99714 3/20 0.70
TDP1 Q9NUW8 3/20 0.70
AKR1B10 O60218 2/20 0.70
AKR1B1 P15121 2/20 0.70
EPHA2 P29317 2/20 0.70
LMNA P02545 2/20 0.70
EFNA1 P20827 1/20 0.70
PSEN1 P49768 1/20 0.70
PSEN2 P49810 1/20 0.70
APH1B Q8WW43 1/20 0.70
NCSTN Q92542 1/20 0.70
APH1A Q96BI3 1/20 0.70
PSENEN Q9NZ42 1/20 0.70
MEN1 O00255 1/20 0.70
KMT2A Q03164 1/20 0.70
VDR P11473 6/20 0.69
CASP7 P55210 3/20 0.69
TP53 P04637 2/20 0.69
MAPK1 P28482 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492108 1.00 GPBAR1 (0.70) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL26670107 0.87 GPBAR1 (0.73) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL4624060 0.87 GPBAR1 (0.73) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL10385209 0.87 GPBAR1 (0.73) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL3125136 0.87 GPBAR1 (0.73) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL1492238 0.87 GPBAR1 (0.66) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL1492258 0.86 GRIN2A (0.53) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL7125036 0.86 GRIN2A (0.53) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL6064406 0.86 GPBAR1 (0.53) GPBAR1HSD17B10TDP1AKR1B10AKR1B1
SCHEMBL23937024 0.85 GPBAR1 (0.70) GPBAR1HSD17B10TDP1AKR1B10AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020240483-A1 COMBINATION OF A POLYHYDROXYLATED BILE ACID AND A FARNESOID X RECEPTOR AGONIST QING BILE THERAPEUTICS INC. (CA) 2020-12-03 WO disclosed
WO-2011022838-A1 POLYHYDROXYLATED BILE ACIDS FOR TREATMENT OF BILIARY DISORDERS BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2011-03-03 WO disclosed
WO-2010033637-A1 DISSOLUTION OF ARTERIAL PLAQUE Z & Z MEDICAL HOLDINGS, INC. (US) 2010-03-25 WO disclosed